- A single weekly session of brisk interval walking reduces belly fat about as effectively as three sessions per week.
- The Hong Kong trial followed 315 adults with central obesity through a 16-week program.
- Both once-weekly and thrice-weekly groups lost similar fat mass and improved heart fitness.
- Interval training alternates short bursts of effort with easier recovery periods.
- Researchers say this offers a practical alternative for those too busy to exercise multiple days.
Researchers at the University of Hong Kong's School of Public Health have found that a single weekly session of brisk interval walking can reduce body fat and improve heart fitness in adults with central obesity about as well as exercising three times per week. The findings, published in Nature Communications, offer a practical option for adults who cannot fit multiple workouts into a week.
The randomized clinical trial, conducted from September 2021 to September 2024, followed 315 overweight Chinese adults in Hong Kong. All participants had central obesity, a condition marked by excess belly fat that researchers link to cardiovascular disease, metabolic disorders, and a higher risk of early death. Both exercise groups completed 75 minutes of interval training each week — one group in a single session, the other spread across three.
Researchers measured body fat using dual-energy X-ray absorptiometry at three points: before the program, after 16 weeks, and at a 32-week follow-up. At the 16-week mark, both groups had cut total fat mass, body fat percentage, and waist circumference by similar margins, and both improved cardiorespiratory fitness relative to a control group that attended health education sessions instead of exercising.
Short bursts of effort, then recovery
Interval training alternates brief, harder efforts with easier stretches of active recovery. Prior research suggests it trims total and visceral fat in less time than steady, moderate-paced exercise.
Standard guidelines typically recommend interval training three days per week, a schedule many find difficult to maintain because of work, family obligations, or no gym nearby. Studies of so-called weekend warriors — people who pack their exercise into one or two days — have found real benefits, but almost none of that work tested interval training specifically.
Professor Parco Siu Ming-fai, head of the Division of Kinesiology at HKUMed's School of Public Health, said the study aimed to determine whether once-weekly training could match the traditional three-session approach and provide a more accessible alternative.
"While thrice-weekly interval training remains a commonly recommended approach for the therapeutic management of excess adiposity, our findings show that once-weekly interval training offers similar benefits and represents a practical exercise strategy," Siu said.
What the trial asked participants to do
Participants in the control arm sat through a two-and-a-half-hour health education class every other week for four months. The two exercise arms walked briskly at intervals for the same weekly total — 75 minutes — differing only in how that time was carved up.
The study was supported by the General Research Fund of the Research Grants Council, the University Grants Committee of Hong Kong, and the Seed Fund for Basic Research at HKU.
"For many adults with central obesity who struggle to balance work, study, family and other commitments, time constraints are a primary barrier to exercising multiple days per week," Siu said. "Instead of relying solely on high-frequency exercise prescriptions, once-weekly interval training can be considered a feasible and effective alternative."
A free intervention in a booming drug market
The researchers tested one comparison over 16 weeks, not a universal law of fitness. Still, the result points in a direction worth noting: for this group, how the weekly minutes were arranged mattered less than getting them in.
That is a useful finding at a moment when obesity treatment is increasingly a pharmaceutical conversation. The World Health Organization estimates roughly 890 million adults worldwide were living with obesity as of 2022, and the drug industry has moved aggressively to meet that demand with injectables carrying monthly price tags in the hundreds of dollars and side-effect profiles still being mapped in real time. A 75-minute walk costs nothing, requires no prescription, and carries no manufacturer's warning label. Patients weighing their options deserve to hear that the cheapest intervention in the room performed well in a controlled trial.
Sources for this article include:
Please contact us for more information.